Research
Journals
Burke HB: Reflections of a medical student. Perspectives in Biology and Medicine 1986; 29:214-218.
Burke HB. Computers and medicine: A look ahead. JAMA [Pulse]1987; 257:B.
Burke HB. Science, the third world, and social change: A response to "Science for the third world." Perspect Bio Med 1987; 30:558-560.
Burke HB, Henson DE. Criteria for prognostic factors and for an enhanced prognostic system. Cancer 1993;72:3131-5.
Burke HB. Artificial neural networks for cancer research: outcome prediction. Sem Surg Onc 1994;10:73-79.
Burke HB. Increasing the power of surrogate endpoint biomarkers: the aggregation of predictive factors. J Cell Biochem 1994;19S:278-82.
Bostwick DG, Burke HB, Wheeler TM, Chung LWK, Bookstein R, Pretlow TG, et al. The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trials. J Cell Biochem 1994;19S:283-89.
Burke HB, Goodman PH, Rosen DB, Henson DE, Weinstein JN, Harrell Jr. FE, Marks JR, Winchester DP, Bostwick DG. Artificial neural networks improve the accuracy of cancer survival prediction. Cancer 1997;79:857-62.
Burke HB. Henson DE. Histologic grade as a prognostic factor in breast carcinoma. Cancer 1997;80:1703-1705.
Burke HB, Hoang A, Iglehart JD, Marks JR. Predicting response to adjuvant and radiation therapy in early stage breast cancer. Cancer 1998;82:874-7.
Burke HB. Applying artificial neural networks to clinical medicine. J Clin Ligand 1998;21:200-201.
Burke HB, Henson DE. Specimen banks for prognostic factor research. Arch Path Lab Med, 1998;122:871-874.
Burke HB, Henson DE. Evaluating prognostic factors. CME J Gyn Onc 1999;4:244-252.
Lundin M, Lundin J, Burke HB, Toikkanen S, Pylkkanen l, Joensuu H. Artificial neural networks applied to survival prediction in breast cancer. Oncology 1999;57:281-286.
Seiter K, Feldman EJ, Halicka HD, Deptala A, Traganos F, Burke HB, Kancherla R, Ahmed T. Clinical and laboratory evaluation of ATRA modulation of chemoterhapy in acute myelogenous leukemia. Br J Haematol 2000;108:40-47.
Corda RS, Burke HB, Horowitz HW. Adherence with prescription medications among medical professionals. J Southern Med 2000;93:585-589.
Bosze P, Bast RC, Berchuck A, Burke HB, Buller RE, Creasman WT, Dubeau L, Fox H, Geisler HE, Geisler JP, Henson DE, Rustin GJ, Vermorken JB, Wells M, Wilbanks GD. Consensus statements on prognostic factors in epithelial ovarian carcinoma. Eur J Gynaec Oncol 2000;21:513-526.
Burke HB. Discovering clinically significant patterns in microarray generated data. Mol Diagnosis, 2000;5:349-357.
Medhi M, Marshall MC, Burke HB, Hasan R, Nayak D, Reed G, LaFaro R, Southren AL. HbA1c predicts length of stay in patients admitted for coronary artery bypass surgery. Heart Dis 2001;3:77-79
Bostwick DG, Burke HB. Prediction of individual patient outcome in cancer: Comparison of artificial neural networks and Kaplan-Meier methods. Cancer 2001;91:1643-46.
Burke HB. Challenges in dyslipidemia. Heart Disease 2002;4:141-6.
Bostwick DG, Burke HB, Djakiew D, Euling S, Ho SM, Landolph J, Morrison H, Sonawane B, Shifflett T, Waters DJ, Timms B. Human prostate cancer risk factors. Cancer 2004;101(10 Suppl):2371-2490.
Burke HB. Outcome prediction and the future of the TNM staging system, J Natl Cancer Inst 2004;96:1408-9.
Burke HB. Re: Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2005;97:464-5.
Burke HB. Re: Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2005;97:1797.
Burke HB. Proteomics: Analysis of spectral data. Cancer Informatics 2005;1:15-24.
Bostwick DG, Adolfsson J, Burke HB, Damber J-E, Huland H, Pavone-Macaluso M, Waters DJ. Report of the committee on epidemiology and statistical methods in prediction of patient outcome: World Health Organization’s 2004 International Consultation on Prostate Cancer. Scand J Urol Neph, 2005; 39(Suppl 216):94-110.
Chawla LS, Abel L, Mazhari R, Kadambi N, Burke HB, Junker C, Seneff MG, Kimmel PL. Identifying critically ill patients at high-risk for developing acute renal failure: A pilot study. Kidney Int 2005;68:227-80.
Burke HB, Bostwick DG, Meiers I, Montironi R. Prostate cancer outcome: epidemiology and biostatistics. Anal Quant Cytol Histol 2005;27:211-7.
Cahan P, Ahmad AM, Burke H, Fu S, Lai Y, Florea L, Dharker N, Kobrinski T, Kale P, McCaffrey TA. List of list-annotated (LOLA): A database for annotation and comparison of published microarray gene lists. Gene 2005;360:78-82.
Spernak SM, Mintz M, Paulson J, Burke HB, Gadkari M, Faselis C, Joseph JG. Neighborhood racial composition and availability of asthma drugs in retal pharmacies. J Asthma 2005;42:731-5.
Bostwick DG, Waters DJ, Farley ER, Meiers I, Rukstalis D, Cavanaugh WA, Ragde H, Dineen MK, Bahn D, Scionti S, Babian R, Ellis DS, Rewcastle JC, Burke HB, Andriole GL, Onik G, Barqawi AE, Maksem J, Barzell WE. Group consensus reports from the Consensus Conference on Focal Treatment of Prostatic Carcinoma. Urology 2007;70(6 Suppl):42-4.
Burke HB. Power of prediction. Cancer 2008;113:890-2.
Burke HB. War is persuasion. Critical Review 2009;21(1):1-3.
Burke HB. Lessons from the mammography wars. N Engl J Med 2010; 363:2569-2570.
Brown SM, Culver JO, Osann KE, Macdonald DJ, Sand S, Thornton AA, Grant M, Bowen DJ, Metcalfe KA, Burke HB, Robson ME, Friedman S, Weitzel JN. Health literacy, numeracy, and interpretation of graphical breast cancer risk estimates. Patient Educ Couns 2011;83:92-98.
Culver JO, MacDonald DJ, Thornton AA, Sand SR, Grant M, Bowen DJ, Burke H, Garcia N, Metcalfe, KA, Weitzel JN. Development and Evaluation of a Decision Aid for BRCA Carriers with Breast Cancer. J Genet Counsel 2011;20:294-307.
Burke HB. A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA 2011;306:708.
Burke HB, Henson DE. Molecular predictors drive personalized medicine. Cancer Biomarkers, in press.
Pavlovich CP, Cornish TC, Mullins JK, Fradin J, Mettee LZ, Connor JT, Reese AC, Askin FB, Luck R, Epstein JI, Burke HB. High-resolution transrectal ultrasound: A novel technique for enhanced prostate cancer imaging. Submitted to BJU International.
BOOK CHAPTERS
Burke HB, Hutter RVP, Henson DE. Breast Carcinoma. In P Hermanek, MK Gospadoriwicz, DE Henson, RVP Hutter, LH Sobin (eds), UICC Prognostic Factors in Cancer. Berlin: Springer-Verlag, 1995, 165-176.
Burke HB, Rosen DB, Goodman PH. Comparing the prediction accuracy of artificial neural networks and other statistical models for breast cancer survival. In G. Tesauro, D.S. Touretzky, T.K. Leen (eds), Advances in Neural Information Processing Systems 7. Cambridge, MA; MIT Press, 1995, 1063-67.
Burke HB. Statistical analysis of complex systems in biomedicine. In D. Fisher and H. Lenz (eds), Learning from Data: Artificial Intelligence and Statistics V. New York: Springer-Verlag, 1996, 251-258.
Burke HB. The importance of artificial neural networks and biomedicine. In P.E. Keller, S. Hashem, L.J. Kangas, R.T. Kouzes (eds), Applications of Neural Networks in Environment, Energy, and Health. Singapore; World Scientific Publishing Co., 1996, 145-153.
Burke HB. Integrating multiple clinical tests to increase predictive accuracy. In M. Hanausek, Z. Walaszek (eds), Methods in Molecular Biology:, Vol. XX: Tumor Marker Protocols. Totowa, N.J., Humana Press Inc., 1998, Chapter 1, 3 - 10.
Moul JW, Burke HB. Is the evidence for watchful waiting convincing: Argument for treatment of clinically localized prostate cancer. In Greco C, Zelefsky M (eds), Radiotherapy of Prostate Cancer. Australia: Harwood Academic; 2000, 49-54.
Burke HB, Godec CJ. How important is finding prostate cancer early? In D Bostwick et al. (eds.) American Cancer Society’s Complete Guide to Prostate Cancer. Atlanta, GA: American Cancer Society, 2005.
Burke HB. What combination of factors predict my outcome? In D Bostwick et al. (eds.) American Cancer Society’s Complete Guide to Prostate Cancer. Atlanta, GA: American Cancer Society, 2005.